Independent · reader-supportedMedically reviewed by U.S. MDsLive pricing · updated weeklyLegitScript-verified sources onlyFTC-disclosed affiliate linksIndependent · reader-supportedMedically reviewed by U.S. MDsLive pricing · updated weeklyLegitScript-verified sources onlyFTC-disclosed affiliate linksIndependent · reader-supportedMedically reviewed by U.S. MDsLive pricing · updated weeklyLegitScript-verified sources onlyFTC-disclosed affiliate links
Safety guide · Physician-reviewed

Is compounded semaglutide
actually safe?

The honest, physician-reviewed answer — including what changed after the FDA resolved the semaglutide shortage in February 2025.

Written by Thinner Editorial TeamMedically reviewed by Dr. Sarah Chen, MD (Advisory Board)Updated March 12, 2026
The short answer

When prescribed by a licensed U.S. physician and prepared by a LegitScript-verified compounding pharmacy, compounded semaglutide has a safety profile broadly similar to branded semaglutide (Wegovy / Ozempic). It is not FDA-approved as a finished product — sourcing matters more than any other single factor.

What "compounded" actually means

Compounded semaglutide is prepared by state-licensed pharmacies under Section 503A of the Federal Food, Drug, and Cosmetic Act. It uses the same active ingredient (semaglutide) as branded Wegovy and Ozempic. Because it's prepared patient-by-patient rather than mass-manufactured, it is not reviewed by the FDA as a finished product.

This is a normal pharmaceutical practice — licensed pharmacies compound millions of prescriptions each year for patients whose needs aren't met by standard commercial products. The key question for you is not "compounded vs. not compounded" — it's "is this specific pharmacy properly licensed."

What changed in 2025–2026

Regulatory shift

In February 2025 the FDA declared the semaglutide shortage resolved. In April 2025 they did the same for tirzepatide. This ended 503B outsourcing-facility mass-compounding of these drugs. What did not end: 503A patient-specific compounding by licensed pharmacies with a valid individual prescription. That's what the programs we rank use today.

In March 2026 the FDA sent 30 warning letters to telehealth advertisers. None of the programs on our top-3 list received one.

How to spot a legitimate program

  • 1. LegitScript verification. Every program we rank is LegitScript-verified. Look for the badge or search legitscript.com/lookup before signing up.
  • 2. Named prescribing physician. The program should tell you which licensed U.S. physician wrote your prescription — not "our medical team."
  • 3. Sourcing pharmacy on the label. Your shipment should include the compounding pharmacy's name, lot number, expiration date, and phone number.
  • 4. Cancel anytime, no lock-in. Legitimate telehealth programs don't require multi-month contracts. Auto-billing must be clearly disclosed at signup.

Independent, reader-supported. Thinner may earn a commission when you sign up for a program through our links. Editorial rankings are decided by our review team using our public methodology — payouts never move a program up the list. See our full affiliate disclosure.

Frequently asked

Is compounded semaglutide safe?

Compounded semaglutide is prescribed by licensed U.S. physicians and prepared by state-licensed compounding pharmacies. It uses the same active ingredient (semaglutide) as branded Wegovy and Ozempic, but is not FDA-approved as a finished product. Safety depends heavily on the sourcing pharmacy — always confirm your program uses a LegitScript-verified pharmacy.

Is compounded semaglutide the same as Ozempic?

It contains the same active ingredient. It is not bioequivalent to Ozempic or Wegovy under FDA's strict definition, and it is not FDA-approved. Compounded formulations may include additional ingredients (like B12) and are prepared for individual patients by licensed pharmacies.

Is compounded semaglutide still legal in 2026?

Yes — under Section 503A of the Federal Food, Drug, and Cosmetic Act, licensed pharmacies can compound semaglutide for individual patients with a valid prescription. The FDA resolved the semaglutide shortage in February 2025, which ended mass 503B outsourcing-facility compounding but did not end 503A patient-specific compounding.

What are the risks of compounded GLP-1?

The same clinical risks as branded semaglutide (nausea, GI side effects, rare pancreatitis) plus sourcing risk if the pharmacy is not properly licensed. The FDA has issued warnings about non-compliant compounders. Only use programs whose sourcing pharmacies are LegitScript-verified and state-licensed.

How do I verify a program is safe?

Confirm three things: (1) the prescribing physician is licensed in your state (check your state medical board), (2) the compounding pharmacy is LegitScript-verified and appears on the FDA's registered pharmacy list, and (3) the medication ships with a lot number, expiration date, and pharmacy contact info.

Ready to start with a vetted program?

See our LegitScript-verified top picks.

See top programs →

This guide is educational only and does not constitute medical advice. Always consult a licensed clinician before starting or changing any medication.

60-sec matcher · Free
Find my program
Start →